According to our new research study on “Cranial Implants Market Forecast to 2031 –Global Analysis – by Type, End User, and Geography,” the market is anticipated to grow from US$ 1,429.14 million in 2023 and is projected to reach US$ 2,443.48 million by 2031; it is expected to register a CAGR of 6.9% during 2023–2031. An increase in the prevalence of traumatic brain injuries and a surge in elderly populations are contributing to the growing cranial implants market size. However, the risk of implant failure hampers the cranial implants market growth. Further, customized implants are expected to bring in new cranial implants market trends in the coming years.
In terms of revenue, North America dominated the cranial implants market in 2023. It is estimated to dominate the global market during the forecast period. The US is the largest market for cranial implants in the world, and it is estimated to dominate the market during the forecast period as well. TBIs are the cause of a significant number of deaths and emergency room visits in the US. As per Centers for Disease Control and Prevention (CDC) data, the US recorded more than 69,000 TBI-related deaths in 2021, i.e., ~190 deaths per day. There were nearly 214,110 TBI-related hospitalizations in 2020 in the country. TBIs are among the most significant causes of cranial deformities, requiring surgical intervention through implants, contributing to an increased demand for cranial implants. According to the Sports Injury Statistics by Johns Hopkins University, about 30 million children and adolescents participate in some form of sports in the US, and more than 3.5 million children of age 14 or less suffer sports-related injuries each year. These injuries and falls are the common causes of TBIs, leading to a higher demand for cranial implants for surgical interventions and reconstruction.
In April 2024, 3D System received the US Food and Drug Administration (FDA) 510(k) clearance for its VSP PEEK Cranial Implant. The use of an additive manufacturing solution allows the creation of patient-specific cranial implants with up to 85% less material utilization than similar implants produced by traditional machining, leading to significant cost savings on expensive raw materials, such as implantable PEEK. In addition, in April 2024, Longeviti Neuro Solutions (a Maryland-based neurotechnology company) secured a US patent for its ClearFit prosthetic translucent cranial implant, intended for use during neurosurgical procedures.
Cranial Implants Market Analysis
Advancements in 3D Printing with Incorporation of Original Multilayer Technology to Provide Market Opportunities in Future
3D printing, also known as additive manufacturing, allows for the creation of highly customized, patient-specific cranial implants that offer improved fit and functionality compared to traditional implants. The design and production of cranial implants have evolved with the progress in this technology, enabling precise replication of an individual's skull geometry, which reduces the risk of surgical complications and enhances recovery outcomes. The integration of multilayer technology in 3D printing further enhances these benefits. This technology enables the creation of implants with multiple layers, each designed with different properties tailored to specific functions. For instance, one layer might be engineered for structural strength, while another could focus on biocompatibility or flexibility. Multilayered 3D-printed implants can improve osseointegration (bone growth into the implant), reduce the risk of implant rejection, and offer superior protection for the brain.
3D printing allows for faster production times, lower manufacturing costs, and greater flexibility in adapting to complex cranial deformities. These advancements not only improve patient outcomes but also reduce the overall cost of treatment, making cranial implants more accessible to a broader patient population. As a result, advancements 3D printing with the integration of original multilayer technology, offering improved surgical precision, reduced complications, and better long-term performance, present significant opportunities for the cranial implant market.
Cranial Implants Market Report Segmentation Analysis
Key segments that contributed to the derivation of the cranial implants market analysis are type, material, and end user.
- Based on type, the cranial implants market is segmented into parietal, frontal, occipital, temporal, and sphenoid. The parietal segment held the largest cranial implants market share in 2023.
- In terms of material, the cranial implants market is categorized into polymethyl methacrylate, porous polyethylene, and titanium. The polymethyl methacrylate segment dominated the market in 2023.
- In terms of end user, the cranial implants market is categorized into hospitals, trauma centers, and ambulatory surgical centers. The hospitals segment dominated the market in 2023.
Cranial Implants Market: Competitive Landscape and Key Developments
Evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, EUROS SAS, GPC Medical Ltd, Bioplate Inc, 3D Systems Corp, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, and Johnson & Johnson are among the key companies operating in the cranial implants market.
The Bolt Burdon Kemp 2024 report, Government of Canada, Head Injuries in Australia Report, World Health Organization, Brain Injury Association of Waterloo-Wellington are among the primary and secondary sources referred to while preparing the cranial implants market report.